Improving circulating tumor cells enumeration and characterization to predict outcome in first line chemotherapy mCRPC patients

INTRODUCTION: There is a critical need of new surrogate markers for improving the therapeutic selection and monitoring of metastatic prostate cancer patients. Nowadays clinical management of these patients is been driven by biochemical and clinical parameters without enough accuracy to allow a real...

Descripción completa

Detalles Bibliográficos
Autores principales: León-Mateos, Luis, Casas, Helena, Abalo, Alicia, Vieito, María, Abreu, Manuel, Anido, Urbano, Gómez-Tato, Antonio, López, Rafael, Abal, Miguel, Muinelo-Romay, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589615/
https://www.ncbi.nlm.nih.gov/pubmed/28903376
http://dx.doi.org/10.18632/oncotarget.18025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589615/
https://www.ncbi.nlm.nih.gov/pubmed/28903376
http://dx.doi.org/10.18632/oncotarget.18025

Ejemplares similares